The relationship between Kexing and Pfizer

COVID-19 Kelun Pharmaceutical Co., Ltd. Specific Medicine Cooperation Relationship: Pfizer COVID-19 Specific Medicine and Chinese Medicine are the only enterprises in the two cities that can produce Pfizer COVID-19 Specific Medicine. On February 3rd, Kloc-0, Kelun Pharmaceutical replied on the interactive platform: Kelun has submitted an application for oral drug of Pfizer Kangxinguan on MPP platform, and at present Kelun has the research and development capability of this drug. Kelun Pharmaceutical is a leading enterprise in the field of generic drugs and infusion in China. Since its establishment, Kelun Pharmaceutical has been committed to research and development; D and innovation, set up the national postdoctoral research center, won the title of "national key new product" 13, undertook major scientific and technological projects of "major new drug creation" 12, national science and technology support plan 1, and national science and technology foreign aid project 1. Up to now, Collen has applied for more than 4,000 patents and obtained more than 2,000 patents. The research and development of more than 500 major drugs in the fields of tumor, bacterial infection, parenteral nutrition and other diseases were initiated, and the innovative patents were authorized overseas, which marked that Kelun's drug research and development entered a virtuous circle of "imitation drives innovation, innovation drives the future" and successfully entered the international market.